Tone mix
Week by week 50 weeks
Share of Veracyte, Inc.'s 103 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Oct 12, 2026 · tone -99Veracyte (NASDAQ:VCYT) Stock Rating Cut to Buy at Wall Street Zen-96
- Week of Oct 19, 2026 · tone +100Phase III Trial Shows Veracyte's Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer+95
- Week of Jul 21, 2025 · tone +98Veracyte Set to Join S&P SmallCap 600+85
- Week of Oct 26, 2026 · tone +94Veracyte's Decipher Can Help Men Detect Prostate Cancer+82
- Week of Jan 26, 2026 · tone +100Veracyte, Inc. (VCYT) Sees Analyst Support as Guggenheim Reaffirms Buy Rating+73
- Week of Nov 17, 2025 · tone +100Veracyte (NASDAQ:VCYT) Upgraded at Wall Street Zen+68
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Veracyte, Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 7 | -57 |
| Last 30 sessions | 12 | -17 |
| Last 90 sessions | 31 | +5 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
5 headlines, average tone -80: 0 positive, 1 neutral and 4 negative. Showing all 5.
- www.rttnews.com · 2 outletsVeracyte Stock Plunges 55% Despite Higher Q3 Profit And RevenueNegative
- www.investors.com · 1 outletVeracyte Stock Crashes Almost 40% On Seismic Shift For Its Best-Selling TestNegative
- seekingalpha.com · 1 outletVeracyte stock downgraded at Leerink on guidance cut (VCYT)Negative
- www.themarketsdaily.com · 1 outletVeracyte (NASDAQ:VCYT) Share Price Breaks Below 200-Day Moving Average After Analyst DowngradeNegative
- www.fool.com · 1 outletVeracyte (VCYT) Q3 2026 Earnings Call TranscriptNeutral
Show the table · 5 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Veracyte Stock Plunges 55% Despite Higher Q3 Profit And Revenue | www.rttnews.com | 2 | Negative |
| Veracyte Stock Crashes Almost 40% On Seismic Shift For Its Best-Selling Test | www.investors.com | 1 | Negative |
| Veracyte stock downgraded at Leerink on guidance cut (VCYT) | seekingalpha.com | 1 | Negative |
| Veracyte (NASDAQ:VCYT) Share Price Breaks Below 200-Day Moving Average After Analyst Downgrade | www.themarketsdaily.com | 1 | Negative |
| Veracyte (VCYT) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, November 5, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletVeracyte (NASDAQ:VCYT) Issues Earnings ResultsNeutral
- www.manilatimes.net · 1 outletVeracyte Announces Third Quarter 2026 Financial ResultsNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Veracyte (NASDAQ:VCYT) Issues Earnings Results | www.themarketsdaily.com | 1 | Neutral |
| Veracyte Announces Third Quarter 2026 Financial Results | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
1 headline, average tone +94: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.finanzen.ch · 2 outletsVeracyte's Decipher Can Help Men Detect Prostate CancerPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Veracyte's Decipher Can Help Men Detect Prostate Cancer | www.finanzen.ch | 2 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletPhase III Trial Shows Veracyte's Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate CancerPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Phase III Trial Shows Veracyte's Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer | www.manilatimes.net | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 12, 2026
1 headline, average tone -99: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.dailypolitical.com · 1 outletVeracyte (NASDAQ:VCYT) Stock Rating Cut to Buy at Wall Street ZenNegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Veracyte (NASDAQ:VCYT) Stock Rating Cut to Buy at Wall Street Zen | www.dailypolitical.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Veracyte, Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.